Lin Ding

591 total citations
23 papers, 412 citations indexed

About

Lin Ding is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lin Ding has authored 23 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Lin Ding's work include Immune cells in cancer (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Immune Cell Function and Interaction (5 papers). Lin Ding is often cited by papers focused on Immune cells in cancer (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Immune Cell Function and Interaction (5 papers). Lin Ding collaborates with scholars based in China, United States and India. Lin Ding's co-authors include Juanita L. Merchant, Tianju Liu, Zhe Wu, Sem H. Phan, Taku Nakashima, Matthew Ullenbruch, Ramón Ocádiz-Ruiz, Biao Hu, Amanda Photenhauer and Kathryn A. Eaton and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Lin Ding

22 papers receiving 407 citations

Peers

Lin Ding

IMMUN

PRM

ONCOL

SURGE

Yun Zhao Chen China

Piotr Wysocki Poland

Chun Xia Liu China

Margherita Correnti Italy

Corey Carter United States

Bryan C. McIntosh United States

Uqba Khan United States

Rebecca L. Maywald United States

Tianzhou Ma United States

Yun Zhao Chen China

Lin Ding

123 ×0.7

IMMUN

82 ×0.6

PRM

86 ×0.7

123 ×1.1

ONCOL

57 ×0.7

SURGE

Citations per year, relative to Lin Ding Lin Ding (= 1×) peers Yun Zhao Chen

Countries citing papers authored by Lin Ding

Since Specialization

Citations

This map shows the geographic impact of Lin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Ding more than expected).

Fields of papers citing papers by Lin Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Ding. The network helps show where Lin Ding may publish in the future.

Co-authorship network of co-authors of Lin Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Ding. A scholar is included among the top collaborators of Lin Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Ding. Lin Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Lin, Tongtong Tian, Jie Liu, et al.. (2025). Deciphering diverse cell‐death patterns to predict the prognosis and potential therapy target of hepatocellular carcinoma patients. View.

Ding, Lin, Chong-Miao Zhang, & Hongyu Jiang. (2025). Lipid-lowering drug clofibric acid promotes conjugative transfer of RP4 plasmid carrying antibiotic resistance genes by multiple mechanisms. Journal of Hazardous Materials. 489. 137560–137560. 2 indexed citations

Yang, Wenjing, Jiyan Wang, Tongtong Tian, et al.. (2024). Optimizing of a suitable protocol for isolating tissue‐derived extracellular vesicles and profiling small RNA patterns in hepatocellular carcinoma. Liver International. 44(10). 2672–2686. 2 indexed citations

Sun, Yun‐Fan, Tong Li, Lin Ding, et al.. (2024). Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. Hepatology. 81(3). 791–807. 38 indexed citations

Ding, Lin, et al.. (2023). Schlafen4+-MDSC in Helicobacter-induced gastric metaplasia reveals role for GTPases. Frontiers in Immunology. 14. 1139391–1139391. 11 indexed citations

Jin, Anli, Yihui Yang, Xi Su, et al.. (2022). High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma. Journal of Clinical Laboratory Analysis. 36(3). e24259–e24259. 13 indexed citations

Liu, Te, Hao Wang, Anli Jin, et al.. (2022). Modulation of the p38 MAPK Pathway by Anisomycin Promotes Ferroptosis of Hepatocellular Carcinoma through Phosphorylation of H3S10. Oxidative Medicine and Cellular Longevity. 2022(1). 6986445–6986445. 28 indexed citations

Chen, Wei, Hao Wang, Tong Li, et al.. (2022). A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion. BMC Medical Genomics. 15(1). 34–34. 5 indexed citations

Ding, Lin, Qian Yu, Shuo Yang, et al.. (2022). Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Immunology. 13. 831101–831101. 17 indexed citations

10.

Ding, Lin, Jayati Chakrabarti, Sulaiman Sheriff, et al.. (2022). Toll-like Receptor 9 Pathway Mediates Schlafen+-MDSC Polarization During Helicobacter-induced Gastric Metaplasias. Gastroenterology. 163(2). 411–425.e4. 24 indexed citations

11.

Ding, Lin, Qian Li, Jayati Chakrabarti, et al.. (2020). MiR130b from Schlafen4 ⁺ MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer. Gut. 69(10). 1750–1761. 49 indexed citations

12.

Ding, Lin, et al.. (2020). Sarcomatoid Carcinoma in the Head and Neck: A Population‐Based Analysis of Outcome and Survival. The Laryngoscope. 131(2). E489–E499. 10 indexed citations

13.

Nakashima, Taku, Tianju Liu, Biao Hu, et al.. (2019). Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis–induced Profibrogenic Alterations in Bone Marrow. American Journal of Respiratory and Critical Care Medicine. 200(8). 1032–1044. 11 indexed citations

14.

Ding, Lin, Tianju Liu, Zhe Wu, et al.. (2016). Bone Marrow CD11c+ Cell–Derived Amphiregulin Promotes Pulmonary Fibrosis. The Journal of Immunology. 197(1). 303–312. 54 indexed citations

15.

Ding, Lin, Mohamad El‐Zaatari, & Juanita L. Merchant. (2016). Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer. Advances in experimental medicine and biology. 908. 441–478. 10 indexed citations

16.

Ding, Lin, Michael M. Hayes, Amanda Photenhauer, et al.. (2016). Schlafen 4–expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia. Journal of Clinical Investigation. 126(8). 2867–2880. 61 indexed citations

17.

Liu, Tianju, Lin Ding, Zhe Wu, Francina Gonzalez De Los Santos, & Sem H. Phan. (2015). Role of dendritic cell-derived amphiregulin in pulmonary fibrosis (CCR5P.203). The Journal of Immunology. 194(1_Supplement). 186.5–186.5. 2 indexed citations

18.

Nakashima, Taku, Tianju Liu, Hongfeng Yu, et al.. (2013). Lung Bone Marrow–derived Hematopoietic Progenitor Cells Enhance Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 188(8). 976–984. 23 indexed citations

19.

Ding, Lin, et al.. (2013). CD69+NK cells contribute to the murine hepatitis virus strain 3-induced murine hepatitis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(4). 505–510. 8 indexed citations

20.

Ding, Lin, Zhuang Wu, Tianju Liu, et al.. (2013). Essential role of stem cell factor–c‐Kit signalling pathway in bleomycin‐induced pulmonary fibrosis. The Journal of Pathology. 230(2). 205–214. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact